Rocket Pharmaceuticals

-$0.33 (-1.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.

CEO
Gaurav Shah
Employees
91
Headquarters
Cranbury, New Jersey
Founded
1999

RCKT Key Statistics

Market Cap
1.78B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
270.62K
High Today
$28.36
Low Today
$27.29
Open Price
$27.64
Volume
194.77K
52 Week High
$67.48
52 Week Low
$26.72

RCKT Earnings

-$1.08
-$0.72
-$0.36
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure